arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

iSpecimen Inc.

ISPC
$2.23 ▲ +0.02 (+0.90%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
7 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
7
Health
Poor
Bearish
auto_awesome

Analytical Summary

iSpecimen Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $10.3M
Dividend Yield
Revenue Growth -79.2%
Op. Margin -465.4%
ROIC -229.7%
FCF / Share $-0.92
Trailing P/E
Price / Book 6.1x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.93M
↓ -79.2%
Net Income Profit after all expenses
$-10.49M
↑ +16.1%
Operating Margin Operating profit as % of sales
-465.4%
↓ -239.7% 0th
FCF / Share Free cash flow per share
$-0.92
↑ +92.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability
0
Financial Health
2
Cash Quality
36

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters